Literature DB >> 11310633

Germline mutations in the CCM1 gene, encoding Krit1, cause cerebral cavernous malformations.

M Lucas1, A F Costa, M Montori, F Solano, M D Zayas, G Izquierdo.   

Abstract

Mutations in the Kritl gene have been recently discovered as the cause of hereditary cerebral cavernous angioma. We sought the possibility that de novo, noninherited mutations of Kritl also cause cavernous angioma. A patient with two cerebral malformations carries a heterozygous deletion of two base pairs (741delTC) in exon VI of the Kritl gene. The deletion initiates a frameshift mutation that, 23 amino acids downstream, encodes a TAA stop triplet replacing a CAT triplet of histidine at exon VII (H271X). Magnetic resonance images of the parents were normal, neither parent carries the 741delTC mutation, and both bear the wild-type sequence of exon VI. These findings document a de novo germline mutation in Kritl gene that causes cerebral cavernous malformations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310633

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Large germline deletions and duplication in isolated cerebral cavernous malformation patients.

Authors:  U Felbor; S Gaetzner; D J Verlaan; R Vijzelaar; G A Rouleau; A M Siegel
Journal:  Neurogenetics       Date:  2007-01-09       Impact factor: 2.660

2.  Genetic Insights into Cerebrovascular Disorders: A Comprehensive Review.

Authors:  Fawaz Al-Mufti; Ahmed Alkanaq; Krishna Amuluru; Rolla Nuoman; Ahmed Abdulrazzaq; Tamarah Sami; Halla Nuoaman; Caroline Hayes-Rosen; Charles J Prestigiacomo; Chirag D Gandhi
Journal:  J Vasc Interv Neurol       Date:  2017-10

Review 3.  Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling.

Authors:  Stefanie Spiegler; Matthias Rath; Christin Paperlein; Ute Felbor
Journal:  Mol Syndromol       Date:  2018-01-25

4.  Clinical impact of CCM mutation detection in familial cavernous angioma.

Authors:  Oguzkan Sürücü; Ulrich Sure; Sabine Gaetzner; Sonja Stahl; Ludwig Benes; Helmut Bertalanffy; Ute Felbor
Journal:  Childs Nerv Syst       Date:  2006-09-16       Impact factor: 1.475

5.  Familial cerebral cavernomas due to a KRIT1 mutation presenting with epilepsy.

Authors:  Sanjeev Rajakulendran; Sreeman Andole; Angus Kennedy
Journal:  BMJ Case Rep       Date:  2011-03-24

6.  Differential gene expression in human cerebrovascular malformations.

Authors:  Robert Shenkar; J Paul Elliott; Katrina Diener; Judith Gault; Ling-Jia Hu; Randall J Cohrs; Tzulip Phang; Lawrence Hunter; Robert E Breeze; Issam A Awad
Journal:  Neurosurgery       Date:  2003-02       Impact factor: 4.654

Review 7.  De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention.

Authors:  Julie Gauthier; Guy A Rouleau
Journal:  Genome Med       Date:  2012-09-25       Impact factor: 11.117

8.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

9.  Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene).

Authors:  Lucía Ortiz; Alzenira F Costa; María L Bellido; Francisca Solano; Jose M García-Moreno; Miguel A Gamero; Guillermo Izquierdo; Amal Chadli; Filipa Falcao; Jose Ferro; Javier Salas; Jose C Alvarez-Cermeño; Mariano Montori; María A Ramos-Arroyo; Alfredo Palomino; Elizabeth Pintado; Miguel Lucas
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

10.  Variable expression of cerebral cavernous malformations in carriers of a premature termination codon in exon 17 of the Krit1 gene.

Authors:  Miguel Lucas; Alzenire F Costa; José M García-Moreno; Francisca Solano; Miguel A Gamero; Guillermo Izquierdo
Journal:  BMC Neurol       Date:  2003-07-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.